BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, December 12, 2024
See today's BioWorld Asia
Home
» A sign of the times in Japan: Astellas shutters two units, hands another to Eurofins
To read the full story,
subscribe
or
sign in
.
A sign of the times in Japan: Astellas shutters two units, hands another to Eurofins
July 5, 2018
By
Catherine Makino
No Comments
TOKYO – Japanese pharmaceutical companies are downsizing, bucking a longstanding practice in the country of providing lifetime employment, even as they try to prepare for the possibility of a shrinking industry.
BioWorld Asia